Polypharmacy is defined as the use of multiple medications by a patient, with 5–10 medications usually accepted as the cutoff. From: Geriatric Rehabilitation, 2018
Cereghino JJ, Brock J, Meter JCV, Pentry JK, Smith LD, White BG. Carbamazepine for epilepsy. Neurology. 1974;24(5):401.
Article CAS PubMed Google Scholar
Smith TW, Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest. 1970, Dec;49(12):2377–86.
Article CAS PubMed PubMed Central Google Scholar
Buchthal F, Svensmark OLE, Schiller PJ. Clinical and electroencephalographic correlations with serum levels of diphenylhydantoin. A.M.a. Arch Neurol. 1960;2(6):624–30.
Article CAS PubMed Google Scholar
Bialer M, Levy RH, Perucca E. Does carbamazepine have a narrow therapeutic plasma concentration range? Ther Drug Monit. 1998, Feb;20(1):56–9.
Article CAS PubMed Google Scholar
Centre For Reviews and Dissemination. Systematic reviews : CRD's guidance for undertaking reviews in health care. York: University of York; 2009.
Google Scholar
Higgins JPT, Green S, Collaboration C. Cochrane handbook for systematic reviews of interventions. Chichester, England. Hoboken: Wiley; 2008.
Book Google Scholar
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC med res Methodol. 2007, Feb;7(1):10.
Article PubMed PubMed Central Google Scholar
Cooney L, Hawcutt D, Sinha I. The evidence for intravenous theophylline levels between 10-20mg/L in children suffering an acute exacerbation of asthma: a systematic review. PLoS One. 2016;11(4):e0153877.
Article PubMed PubMed Central Google Scholar
Konidari A, Anagnostopoulos A, Bonnett LJ, Pirmohamed M, El-Matary W. Thiopurine monitoring in children with inflammatory bowel disease: a systematic review. Br J Clin Pharmacol. 2014;78(3):467–76.
Article CAS PubMed PubMed Central Google Scholar
Sparshatt A, Taylor D, Patel MX, Kapur S. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring. Acta Psychiatr Scand. 2009;120(6):416–28.
Article CAS PubMed Google Scholar
Knight SR, Morris PJ. Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review. Transplantation. 2008;85(12):1675–85.
Article CAS PubMed Google Scholar
Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006, Apr;130(4):1047–53.
Article CAS PubMed Google Scholar
Prybylski JP. Vancomycin trough concentration as a predictor of clinical outcomes in patients with Staphylococcus aureus bacteremia: a meta-analysis of observational studies. Pharmacotherapy. 2015;35(10):889–98.
Article CAS PubMed Google Scholar
Sparshatt A, Taylor D, Patel MX, Kapur S. A systematic review of aripiprazole—dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. J Clin Psychiatry. 2010;71(11):1447–56.
Article CAS PubMed Google Scholar
Zuk DM, Pearson GJ. Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients—a systematic review. Transplant rev. 2009;23:171–7.
Article Google Scholar
Bishara D, Olofinjana O, Sparshatt A, Kapur S, Taylor D, Patel M. Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and response. J Clin Psychopharmacol. 2013;33:329–35.
Article CAS PubMed Google Scholar
Moreau AC, Paul S, Del Tedesco E, Rinaudo-Gaujous M, Boukhadra N, Genin C, et al. Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis. Inflamm Bowel Dis. 2014, Mar;20(3):464–71.
Article PubMed Google Scholar
Cucherat M. Méta-analyse des essais thérapeutiques. France: Masson; 1997.
Google Scholar
Kullar R, Leonard SN, Davis SL, Delgado G, Pogue JM, Wahby KA, et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Pharmacotherapy. 2011;31(5):441–8.
Article CAS PubMed Google Scholar
Rylance GW, Moreland TA. Drug level monitoring in paediatric practice. Arch Dis Child. 1980;55(2):89–98.
Article CAS PubMed PubMed Central Google Scholar
Turner-Warwick M. Study of theophylline plasma levels after oral administration of new theophylline compounds. Br med J. 1957, Jul 13;2(5036):67–9.
Article CAS PubMed PubMed Central Google Scholar
Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13(1):132.
Article PubMed PubMed Central Google Scholar
Core outcome measures in effectiveness trials (COMET) initiative; Available from: //www.comet-initiative.org. Accessed 7 January 2017.
Boers M, Idzerda L, Kirwan JR, Beaton D, Escorpizo R, Boonen A, et al. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11. J Rheumatol. 2014;41(5):978–85.
Article PubMed Google Scholar
Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012;13(1):103.
Article PubMed PubMed Central Google Scholar
Loke YK, Price D, Herxheimer A. Systematic reviews of adverse effects: framework for a structured approach. BMC med res Methodol. 2007, Jul;7(1):1.
Article Google Scholar
Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics. 2005;115(3):655–61.
Article PubMed Google Scholar
Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics. 2001;107(2):217–21.
Article CAS PubMed Google Scholar
Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000;83(3):F177–81.
Article CAS PubMed PubMed Central Google Scholar
Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Dolores Pilloni M, et al. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. 2012;13(4):474–90.
Article CAS PubMed Google Scholar
Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J med. 1989;321(22):1489–93.
Article CAS PubMed Google Scholar
Greeff O, Van Tonder J, Cromarty D, Lowman W, Becker P, Nell M. A multi-centre, phase IV study to evaluate the steady-state plasma concentration and serum bactericidal activity of a generic teicoplanin preparation. South Afr J Infect Dis. 2015;30(3):89–94.
Google Scholar
Katrak P, Bialocerkowski AE, Massy-Westropp N, Kumar S, Grimmer KA. A systematic review of the content of critical appraisal tools. BMC med res Methodol. 2004;4:22.
Article PubMed PubMed Central Google Scholar
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355:i4919.
Article PubMed PubMed Central Google Scholar
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ: British Medical Journal. 2011, Oct;343:d5928.
Article PubMed PubMed Central Google Scholar
Critical appraisal skills programme. 12 questions to help you make sense of cohort study; Available from: //media.wix.com/ugd/dded87_e37a4ab637fe46a0869f9f977dacf134.pdf. Accessed 11 January 2017.
National institute of clinical excellence defined criteria for quality assessment of case series; Available from: //www.nice.org.uk/guidance/cg3/resources/appendix-4-quality-of-case-series-form2. Accessed 11 January 2017.
Page 2
Cooney 2016 [8] | Aminophylline | Asthma | No | 12 | Yes | No restrictions | No | Medine, CINAHL, Cochrane Central, and Web of Science | Cochrane tool for assessment of risk of bias [35], CASP tool [36] | No |
Sparshatt 2009 [10] | Amisulpride | Schizophrenia/schizoaffective disorder | No | 10 | Yes | No restrictions | No | Embase, Medline and PubMed | None | No |
Sparshatt 2010 [14] | Aripirazole | No specific diagnosis | No | 8 | No | No restrictions | Yes | Embase, Medline, and PubMed | None | No |
Knight 2008 [11] | Mycophenolate Mofetil | Transplant patients | No | 12 | Yes | RCTs, Observational studies | No | Medline, Embase, Cochrane Central, Transplant Library, Clinical trial registries | None | No |
Zuk 2009 [15] | Mycophenolate Mofetil | Heart transplant | No | 7 | No | No restrictions | Yes | Medline Embase | None | No |
Bishara 2013 [16] | Olanzapine | Schizophrenia/schizoaffective disorder/bipolar disorder | No | 30 | Yes | No restrictions | Yes | PubMed, Medline, Embase | None | Yes |
Konidari 2014 [9] | Thiopurine | IBD | No | 15 | Yes | RCTs, Observational studies | Yes | PubMed, Medline, UK national health system database | NICE defined criteria for quality assessment of case series [37] | No |
Moreau 2014 [17] | Thiopurine | IBD | Yes | 17 | No | No restrictions | Yes | Medline, Cochrane Library, DirectScience, and Google Scholar | Nonea | Yes |
Osterman 2006 [12] | Thiopurine | IBD | No | 12 | No | No restrictions | No | Medline, PubMed Plus | None | Yes |
Prybylski 2015 [13] | Vancomycin | S. aureus bacteraemia | No | 14 | No | Observational studies | No | PubMed | None | Yes |
- RoB Risk Of bias, IBD Inflammatory Bowel Disease, RCT Randomised controlled trial, CENTRAL Central Register of Controlled Trials
- aMoreau et al. used the MOOSE consensus statement to assess reporting quality, but do not report the results of their assessment